Study of Nuvaring Acceptability, Adherence and Biological Effects Among HIV-negative Women in Kenya
Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
One arm clinical trial of Nuvaring use for six months among 200 previously contracepting
HIV-negative women (COCPs or DMPA) aged 18-35 in Kenya, where no vaginal rings are
licensed/available for contraception or other indications. This was meant to be a formative
research study to understand the predictors of acceptability and adherence to a contraceptive
vaginal ring, and its immunoogical and microbiological effects over six months of product
use.